Bristol Myers (Mexico) Today
| BMY Stock | MXN 1,222 16.45 1.36% |
Performance12 of 100
| Odds Of DistressLess than 9
|
Bristol Myers is trading at 1222.00 as of the 28th of November 2024; that is 1.36% up since the beginning of the trading day. The stock's open price was 1205.55. Bristol Myers has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Bristol Myers Squibb are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. BRISTOL MYERS operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. The company has 2.13 B outstanding shares. More on Bristol Myers Squibb
Moving against Bristol Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bristol Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bristol Myers' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bristol Myers or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Ann Judge |
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
Bristol Myers Squibb (BMY) is traded on Mexican Exchange in Mexico and employs 41 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.87 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol Myers's market, we take the total number of its shares issued and multiply it by Bristol Myers's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bristol Myers Squibb operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 2.13 B outstanding shares.
Bristol Myers Squibb has accumulated about 29.36 B in cash with 16.21 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 17.95.
Check Bristol Myers Probability Of Bankruptcy
Ownership AllocationBristol Myers holds a total of 2.13 Billion outstanding shares. The majority of Bristol Myers Squibb outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bristol Myers Squibb to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bristol Myers. Please pay attention to any change in the institutional holdings of Bristol Myers Squibb as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bristol Ownership Details
Bristol Myers Squibb Risk Profiles
Although Bristol Myers' alpha and beta are two of the key measurements used to evaluate Bristol Myers' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.5 | |||
| Semi Deviation | 1.26 | |||
| Standard Deviation | 2.44 | |||
| Variance | 5.94 |
Bristol Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bristol Myers without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Bristol Myers Corporate Management
Elected by the shareholders, the Bristol Myers' board of directors comprises two types of representatives: Bristol Myers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bristol. The board's role is to monitor Bristol Myers' management team and ensure that shareholders' interests are well served. Bristol Myers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bristol Myers' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jitendra Tyagi | Head India | Profile | |
| Cari Gallman | VP Officer | Profile | |
| David Elkins | Ex CFO | Profile | |
| BCH BM | Ex Devel | Profile | |
| Giovanni MD | Chairman CEO | Profile | |
| Greg Meyers | Ex Officer | Profile |
Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.